Obesity drugmaker BioAge targets $158 million in IPO

The company is offering 7.5 million shares for $17 to $19 apiece, according to a filing Wednesday.

Tomas K - Moderator Tomas K - Moderator
Sep 18, 2024 - 23:00
Obesity drugmaker BioAge targets $158 million in IPO
The company is offering 7.5 million shares for $17 to $19 apiece, according to a filing Wednesday. Read More
Read More